SE7610501L - Nya n-aryl-n(1-l-4-piperidinyl)-arylacetamider - Google Patents

Nya n-aryl-n(1-l-4-piperidinyl)-arylacetamider

Info

Publication number
SE7610501L
SE7610501L SE7610501A SE7610501A SE7610501L SE 7610501 L SE7610501 L SE 7610501L SE 7610501 A SE7610501 A SE 7610501A SE 7610501 A SE7610501 A SE 7610501A SE 7610501 L SE7610501 L SE 7610501L
Authority
SE
Sweden
Prior art keywords
arylacetamides
piperidinyl
aryl
new
formula
Prior art date
Application number
SE7610501A
Other languages
English (en)
Other versions
SE427839B (sv
Inventor
S Sanczuk
H K F Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE7610501L publication Critical patent/SE7610501L/sv
Publication of SE427839B publication Critical patent/SE427839B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7610501A 1975-09-23 1976-09-22 Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider SE427839B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (2)

Publication Number Publication Date
SE7610501L true SE7610501L (sv) 1977-03-24
SE427839B SE427839B (sv) 1983-05-09

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7610501A SE427839B (sv) 1975-09-23 1976-09-22 Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider

Country Status (29)

Country Link
JP (1) JPS6016417B2 (sv)
AT (1) AT363935B (sv)
AU (1) AU510029B2 (sv)
BG (1) BG27543A3 (sv)
CA (1) CA1068271A (sv)
CH (1) CH628623A5 (sv)
CS (1) CS222663B2 (sv)
DE (1) DE2642856A1 (sv)
DK (1) DK150478C (sv)
ES (1) ES451768A1 (sv)
FI (1) FI61482C (sv)
FR (1) FR2325377A1 (sv)
GB (1) GB1539473A (sv)
GR (1) GR58469B (sv)
HU (1) HU172964B (sv)
IE (1) IE43802B1 (sv)
IL (1) IL50522A (sv)
IT (1) IT1073893B (sv)
LU (1) LU75837A1 (sv)
NL (1) NL187267C (sv)
NO (1) NO147672C (sv)
NZ (1) NZ181972A (sv)
PH (1) PH12497A (sv)
PL (2) PL117323B1 (sv)
PT (1) PT65631B (sv)
RO (1) RO70079A (sv)
SE (1) SE427839B (sv)
SU (1) SU747424A3 (sv)
YU (1) YU39973B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
MX2009011416A (es) 2007-04-23 2009-11-05 Janssen Pharmaceutica Nv Tia(di)azoles como antagonistas del receptor de dopamina 2 de disociacion rapida.
RS52518B (sr) 2007-04-23 2013-04-30 Janssen Pharmaceutica N.V. Derivati 4-alkoksipiridazina kao brzo disocirajući dopamin 2 receptorski antagonisti
US20100137368A1 (en) * 2007-04-23 2010-06-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CA2729313C (en) 2008-07-03 2016-08-30 Janssen Pharmaceutica Nv Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists
ES2622161T3 (es) 2008-07-31 2017-07-05 Janssen Pharmaceutica, N.V. Piridinas sustituidas con piperazin-1-il-trifluorometilo como antagonistas del receptor de la dopamina 2 de disociación rápida
CN118496638B (zh) * 2024-07-22 2024-11-22 海安浩驰科技有限公司 一种抗紫外车窗膜及其制备方法

Also Published As

Publication number Publication date
NZ181972A (en) 1978-07-28
CA1068271A (en) 1979-12-18
AU1787876A (en) 1978-03-23
FR2325377A1 (fr) 1977-04-22
FI61482C (fi) 1982-08-10
YU39973B (en) 1985-06-30
HU172964B (hu) 1979-01-28
GB1539473A (en) 1979-01-31
NO147672C (no) 1983-05-25
SU747424A3 (ru) 1980-07-23
FR2325377B1 (sv) 1980-04-18
NL187267C (nl) 1991-08-01
IE43802L (en) 1977-03-23
DE2642856C2 (sv) 1990-06-21
SE427839B (sv) 1983-05-09
DK150478C (da) 1987-10-05
NL7610513A (nl) 1977-03-25
CH628623A5 (en) 1982-03-15
DK150478B (da) 1987-03-09
FI762698A7 (sv) 1977-03-24
YU233676A (en) 1983-01-21
PL117323B1 (en) 1981-07-31
FI61482B (fi) 1982-04-30
IE43802B1 (en) 1981-06-03
IT1073893B (it) 1985-04-17
IL50522A0 (en) 1976-11-30
JPS6016417B2 (ja) 1985-04-25
DE2642856A1 (de) 1977-03-24
PT65631B (en) 1978-07-05
PH12497A (en) 1979-04-05
DK427876A (da) 1977-03-24
LU75837A1 (sv) 1977-05-04
CS222663B2 (en) 1983-07-29
GR58469B (en) 1977-10-14
AT363935B (de) 1981-09-10
NO763054L (no) 1977-03-24
PT65631A (en) 1976-10-01
BG27543A3 (bg) 1979-11-12
NO147672B (no) 1983-02-14
JPS5239683A (en) 1977-03-28
PL192578A1 (pl) 1979-02-26
ES451768A1 (es) 1978-05-01
NL187267B (nl) 1991-03-01
ATA702976A (de) 1981-02-15
RO70079A (ro) 1982-10-26
AU510029B2 (en) 1980-06-05
IL50522A (en) 1979-09-30

Similar Documents

Publication Publication Date Title
DK136714B (da) Analogifremgangsmåde til fremstilling af substituerede piperidinderivater eller syreadditionssalte deraf.
SE7612366L (sv) Nya hydroxibensylmalonsyra-derivat.
SE7604052L (sv) Nya erytromycinderivat och forfarande for framstellning derav
SE416298B (sv) Forfarande for framstellning av nya bensimidazolinon derivat
SE7703842L (sv) Nya piperazin- och piperinderivat
SE7610501L (sv) Nya n-aryl-n(1-l-4-piperidinyl)-arylacetamider
SE7608265L (sv) 1-(bensazolylalkyl)-piperidiner
SE7611137L (sv) 1-bensazolylalkyl-4-substituerade piperidiner
SE7514271L (sv) Sett att framstella nya 1,3-disubstituerade propanol-(2)-derivat
SE7604476L (sv) Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar
SE7604093L (sv) Anorexa foreningar
SE424553B (sv) Forfarande for framstellning av nya indazol-derivat
SE7701187L (sv) Nya piperazinderivat och sett att framstella desamma
SE431539B (sv) Analogiforfaranden for framstellning av nya bensylalkoholderivat
GB1471847A (en) Dibenzofuran derivatives
ES414955A1 (es) Procedimiento para la preparacion de 4-(4-bifenilil)-buta- noles.
SU674671A3 (ru) Способ получени производных пирролидина
GR33644B (el) Μεθοδος δια την παρασκευην νεων αλογονουποκατεστημενων τετραυδρο-κιναζολινων.
SE7508793L (sv) Antibiotiska derivat av xk-62-2 samt forfarande for framstellning derav
SE7612961L (sv) Tienamycinderivat
SE7701845L (sv) Forfarande for framstellning av l-sulfonyl-5(6)-substituerade bensimidazoler
SE7604044L (sv) Forfarande for framstellning av nya heterocykliska foreningar
ES398080A1 (es) Procedimiento para la preparacion de derivados de 1-vinil- carbonil-piperazina.
ES391768A1 (es) Procedimiento para la preparacion de derivados de tropan-3-ol.
SE412907B (sv) Forfarande for framstellning av nya n-2'-karboxifenyl-4-klorantranilsyror

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7610501-4

Effective date: 19910409

Format of ref document f/p: F